Journal article
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
Abstract
BACKGROUND: There are various regimens for thromboprophylaxis after hip replacement. Low-molecular-weight heparins such as enoxaparin predominantly inhibit factor Xa but also inhibit thrombin to some degree. Orally active, specific factor Xa inhibitors such as apixaban may provide effective thromboprophylaxis with a lower risk of bleeding and improved ease of use.
METHODS: In this double-blind, double-dummy study, we randomly assigned 5407 …
Authors
Lassen MR; Gallus A; Raskob GE; Pineo G; Chen D; Ramirez LM
Journal
New England Journal of Medicine, Vol. 363, No. 26, pp. 2487–2498
Publisher
Massachusetts Medical Society
Publication Date
December 23, 2010
DOI
10.1056/nejmoa1006885
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralAdultAgedAged, 80 and overAnticoagulantsArthroplasty, Replacement, HipConfidence IntervalsDouble-Blind MethodEnoxaparinFactor Xa InhibitorsFemaleHemorrhageHumansInjections, SubcutaneousMaleMiddle AgedPostoperative ComplicationsPyrazolesPyridonesTreatment OutcomeVenous ThromboembolismYoung Adult